Chao Ding
Publications
SafeMed-R1: Clinician-Audited Safety and Ethics Alignment for Medical Large Language Models
Large language models(LLMs) increasingly match expert performance on licensing examinations, yet routine clinical use remains limited because governance requires auditable reasoning, safety and ethics alignment, and resilience to adversarial misuse. Here we present SafeMed-R1, trained with a traceable Clinical Trust Signals(CTS) pipeline that links each reasoning instance to clinician rubric scores and edit histories, and aligned through safety and ethics supervision and red team stress testing. SafeMed-R1 attains a macro-averaged accuracy of 79.6% across clinical benchmarks. Under adversarial safety testing, it shows the lowest aggregated risk and reduces unsafe outputs by about 3 to 5% relative to its baseline. In a paired expert study of 30 medication safety vignettes, SafeMed-R1 matches PGY1 and PGY2 residents on medical correctness and scores higher for medication safety, guideline consistency, and clinical usefulness. Collectively, these results suggest that clinician-audited supervision provenance, together with domain-tailored safety and ethics alignment, can strengthen governance-relevant evidence without relying on inference-time retrieval or citation grounding.
IBISAgent: Reinforcing Pixel-Level Visual Reasoning in MLLMs for Universal Biomedical Object Referring and Segmentation
Recent research on medical MLLMs has gradually shifted its focus from image-level understanding to fine-grained, pixel-level comprehension. Although segmentation serves as the foundation for pixel-level understanding, existing approaches face two major challenges. First, they introduce implicit segmentation tokens and require simultaneous fine-tuning of both the MLLM and external pixel decoders, which increases the risk of catastrophic forgetting and limits generalization to out-of-domain scenarios. Second, most methods rely on single-pass reasoning and lack the capability to iteratively refine segmentation results, leading to suboptimal performance. To overcome these limitations, we propose a novel agentic MLLM, named IBISAgent, that reformulates segmentation as a vision-centric, multi-step decision-making process. IBISAgent enables MLLMs to generate interleaved reasoning and text-based click actions, invoke segmentation tools, and produce high-quality masks without architectural modifications. By iteratively performing multi-step visual reasoning on masked image features, IBISAgent naturally supports mask refinement and promotes the development of pixel-level visual reasoning capabilities. We further design a two-stage training framework consisting of cold-start supervised fine-tuning and agentic reinforcement learning with tailored, fine-grained rewards, enhancing the model's robustness in complex medical referring and reasoning segmentation tasks. Extensive experiments demonstrate that IBISAgent consistently outperforms both closed-source and open-source SOTA methods. All datasets, code, and trained models will be released publicly.